Stacy Price
Chief Tech/Sci/R&D Officer en INVIVYD, INC. .
Fortuna: - $ al 31/03/2024
Perfil
Stacy Price is currently the Chief Technology & Manufacturing Officer at Invivyd, Inc. Prior to this role, Stacy held positions as the Senior Vice President-Technical Operations at Alaunos Therapeutics, Inc. and Chief Technical Officer at Akouos, Inc. Stacy has also received undergraduate and graduate degrees from Tufts University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
INVIVYD, INC.
-.--% | 18/12/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Stacy Price
| Empresas | Cargo | Inicio |
|---|---|---|
| INVIVYD, INC. | Chief Tech/Sci/R&D Officer | 01/03/2023 |
Antiguos cargos conocidos de Stacy Price.
| Empresas | Cargo | Fin |
|---|---|---|
| AKOUOS | Chief Tech/Sci/R&D Officer | - |
| ALAUNOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Formación de Stacy Price.
| Tufts University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Stacy Price
